Quanticate is relocating its U.S. office in Boston to North Carolina’s Research Triangle. This expansion follows several new partnerships with top 10 pharma companies to provide global functional support, particularly in the areas of biostatistics and statistical programming. The new office is scheduled to open in 3Q13.

“Due to a number of large-scale partnerships being awarded to Quanticate, we saw the need to expand our U.S. presence and relocate our U.S. headquarters to the Research Triangle in NC,” said Daniel Chapple, Quanticate’s chief commercial officer. “This move provides us with the opportunity of operating within a scalable and growing business region dedicated to the life science industry. “By expanding our U.S. presence we are able to provide additional experienced lead resources in our tailored solutions to clients as well as provide efficiencies through our on-shore, near-shore and off-shore capabilities,” said Mr. Chapple.